Total Payments
$1,382
2022 Payments
$37.74
Companies
17
Transactions
69
Medicare Patients
3,546
Medicare Billing
$341,783
Payment Breakdown by Category
Food & Beverage$1,131 (81.8%)
Education$250.98 (18.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,131 | 66 | 81.8% |
| Education | $250.98 | 3 | 18.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $359.40 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $269.59 | 13 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $122.21 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $106.06 | 8 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $93.58 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.27 | 5 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $75.99 | 6 | $0 (2021) |
| Amgen Inc. | $73.58 | 5 | $0 (2019) |
| Novo Nordisk Inc | $34.93 | 2 | $0 (2021) |
| Lundbeck LLC | $30.57 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $37.74 | 2 | Novartis Pharmaceuticals Corporation ($24.56) |
| 2021 | $324.18 | 19 | Novartis Pharmaceuticals Corporation ($97.65) |
| 2020 | $364.58 | 15 | Janssen Pharmaceuticals, Inc ($165.01) |
| 2019 | $491.35 | 22 | Astellas Pharma US Inc ($212.49) |
| 2018 | $144.76 | 10 | AstraZeneca Pharmaceuticals LP ($61.18) |
| 2017 | $19.07 | 1 | Novo Nordisk Inc ($19.07) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/08/2022 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: Cardiology | ||||||
| 11/02/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/28/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: DIABETES | ||||||
| 05/12/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: DIABETES | ||||||
| 04/01/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/17/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: DIABETES | ||||||
| 03/15/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Heart Failure | ||||||
| 03/10/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 01/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: DIABETES | ||||||
| 01/26/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2021 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/19/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: STRUCTURAL HEART | ||||||
| 10/22/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,622 | 2,245 | $582,007 | $145,108 |
| 2022 | 20 | 1,329 | 1,829 | $524,507 | $126,534 |
| 2021 | 10 | 595 | 736 | $267,806 | $70,140 |
Total Patients
3,546
Total Services
4,810
Medicare Billing
$341,783
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 278 | 573 | $137,268 | $36,052 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 372 | $141,774 | $32,409 | 22.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 199 | 210 | $83,110 | $21,208 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 118 | 119 | $67,680 | $16,392 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 158 | 160 | $32,600 | $8,366 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $26,440 | $6,829 | 25.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 14 | 14 | $17,780 | $4,744 | 26.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 43 | 50 | $15,810 | $4,119 | 26.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 180 | 261 | $11,465 | $2,679 | 23.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 14 | 28 | $9,528 | $2,525 | 26.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 11 | 44 | $8,072 | $1,969 | 24.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 16 | $5,216 | $1,392 | 26.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 22 | 22 | $4,576 | $1,093 | 23.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 56 | 65 | $3,439 | $897.28 | 26.1% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2023 | 13 | 13 | $3,530 | $871.08 | 24.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 12 | 12 | $2,724 | $727.32 | 26.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 11 | 11 | $2,332 | $553.85 | 23.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 22 | 22 | $1,686 | $450.34 | 26.7% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 14 | 14 | $1,526 | $405.72 | 26.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 18 | 18 | $1,350 | $355.68 | 26.3% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 35 | 36 | $1,260 | $336.24 | 26.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 12 | $752.00 | $200.28 | 26.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 60 | 70 | $694.00 | $166.29 | 24.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $502.00 | $132.96 | 26.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 14 | 19 | $475.00 | $124.26 | 26.2% |
About Junhong Gui
Junhong Gui is a Cardiovascular Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1922437169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Junhong Gui has received a total of $1,382 in payments from pharmaceutical and medical device companies, with $37.74 received in 2022. These payments were reported across 69 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,131).
As a Medicare-enrolled provider, Gui has provided services to 3,546 Medicare beneficiaries, totaling 4,810 services with total Medicare billing of $341,783. Data is available for 3 years (2021–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Orlando, FL
- Active Since 11/08/2013
- Last Updated 08/05/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922437169
Products in Payments
- XARELTO (Drug) $269.59
- LEXISCAN (Drug) $108.42
- ENTRESTO (Drug) $97.65
- WATCHMAN (Device) $93.58
- LifeVest (Device) $75.99
- JARDIANCE (Drug) $64.39
- FARXIGA (Drug) $59.76
- Corlanor (Drug) $50.30
- BRILINTA (Drug) $46.30
- NORTHERA (Drug) $30.57
- PRALUENT (Biological) $26.22
- PRADAXA (Drug) $25.88
- CardioMEMS HF System (Device) $25.60
- LEQVIO (Drug) $24.56
- Repatha (Biological) $23.28
- Vascepa (Drug) $19.90
- Victoza (Drug) $19.07
- JUXTAPID (Drug) $18.41
- Ozempic (Drug) $15.86
- Assure WCD (Device) $13.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orlando
Naveen Bellam, M.d, M.D
Cardiovascular Disease — Payments: $315,652
Cardiovascular Disease $315,652
Dr. Bruce Stein, Md, MD
Cardiovascular Disease — Payments: $291,287
Cardiovascular Disease $291,287
Carlos Zamora, M.d, M.D
Cardiovascular Disease — Payments: $215,909
Cardiovascular Disease $215,909
Nirav Raval, Md, MD
Cardiovascular Disease — Payments: $171,358
Cardiovascular Disease $171,358
James Tarver, M.d, M.D
Cardiovascular Disease — Payments: $133,743
Cardiovascular Disease $133,743
Aurelio Duran, M.d, M.D
Cardiovascular Disease — Payments: $110,928
Cardiovascular Disease $110,928